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Objective. HIV and tuberculosis represent diseases of major public health importance worldwide. Very little is known about HIVTB coinfection among pregnant women, especially from industrialized settings. In this study, we examined the association between
TB, HIV, and HIV-TB coinfection among pregnant mothers and obstetric complications, alcohol use, drug abuse, and depression.
Method. We examined inpatient hospital discharges in the United States from January 1, 2002, through December 31, 2014. We
employed multivariable survey logistic regression to generate adjusted estimates for the association between infection status and
study outcomes. Results. We analyzed approximately 57 million records of pregnant women and their delivery information. HIVTB coinfection was associated with the highest risks for several obstetric complications, alcohol use, and drug abuse. The risk
for alcohol abuse was more than twice as high among HIV-monoinfected as compared to TB-monoinfected mothers. That risk
gap more than doubled with HIV-TB coinfection. Both HIV-monoinfected and HIV-TB coinfected mothers experienced similarly
increased risks for depression. Conclusions. Mothers with HIV-TB coinfection experienced relatively heightened risks for obstetric
complications, alcohol use, and drug abuse. The findings of this study underscore the importance of augmenting and enhancing
social and structural support systems for HIV-TB coinfected pregnant women.

1. Introduction
Human Immunodeficiency Virus (HIV) and tuberculosis
(TB) disease represent health issues of major public importance worldwide. Approximately one in three individuals is
infected with Mycobacterium tuberculosis globally, and HIV is
the main risk factor of active tuberculosis disease, increasing
the risk of latent TB reactivation 20-fold [1]. Tuberculosis
kills more than 1 million women per year, and it is estimated
that 646 million women and girls are already infected
with tuberculosis [2]. Among women aged 15–44 years in
developing countries, tuberculosis is the third most common
cause of morbidity and mortality combined and kills more
women than any other infectious disease, including malaria

and AIDS [3]. HIV-TB coinfected individuals are at greater
risk for relapse following treatment as well as increased
chances of drug resistance to anti-TB drugs [4–8]. Even
in industrialized settings with good healthcare access and
antiretroviral therapy (ART) availability, HIV-TB coinfection
is associated with high mortality [9].
A recent study suggests that the rate of TB among pregnant women in the United States (US) is climbing, although
the increase appears to be as a result of an upsurge in extrapulmonary disease as well as inclusion of pregnant women with
reported history of tuberculosis [10]. This poses a concern
regarding the effects of TB disease in HIV-positive mothers.
Although HIV and TB among pregnant women have been
studied separately, the impact of HIV-TB coinfection among
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affected mothers remains poorly defined or understood. The
aim of this study is to determine the association between TB,
HIV, and HIV-TB coinfection with pregnancy complications,
alcohol use, drug abuse, and depression using a highly reliable
and validated population-based dataset. Drawing from more
than 57 million pregnancy-related and delivery admissions,
this study is the largest in the world on HIV-TB coinfection
given the sample size of the source population.

2. Materials and Methods
We used data from the Nationwide Inpatient Sample (NIS)
covering the period from January 1, 2002, through December
31, 2014, for this analysis. The NIS dataset is made available
by the Healthcare Cost and Utilization Project (HCUP) and
currently constitutes the largest all-payer, publicly available
inpatient database in the US [11]. To create the sample
annually, HCUP employs a two-stage cluster sampling design
that first stratifies all nonfederal community hospitals from
participating states by five major hospital characteristics:
rural/urban location, number of beds, geographic region,
teaching status, and ownership. Then, 20% of hospitals from
each unique stratum were selected using a systematic random
sampling technique [12]. In the second stage, all inpatient discharges from hospitals selected during stage 1 were selected
for inclusion in the NIS. Beginning in 2012, the NIS sampling
strategy was changed from keeping all discharges from a
sample of hospitals to drawing a sample of discharges from
all hospitals. The NIS approximates a 20% systematic sample
that is representative of the population of all discharges on
critical hospital and patient characteristics [12]. To assess the
study’s primary exposures, we scanned ICD-9-CM codes (the
principal diagnosis and up to 24 secondary diagnoses) in each
woman’s discharge record for an indication of HIV and TB
status.
Individual-level sociodemographic and behavioral characteristics were also extracted from the NIS databases. Maternal age in years was classified into three categories: 13–24,
25–34, and 35–49. Self-reported maternal race/ethnicity was
first based on ethnicity (Hispanic or non-Hispanic [NH]),
and the NH group was further subdivided by race (white,
black, or other). Median household income, which served
as a proxy for socioeconomic status, was estimated using
the patient’s zip code and subsequently grouped into quartiles. We classified the primary payer for hospital admission into three categories: government (Medicare/Medicaid),
private (commercial carriers, private health maintenance
organization [HMOs], and preferred provider organization
[PPOs]), and other sources (e.g., self-pay and charity).
Due to their strong associations with HIV infection, we
also used ICD-9-CM codes to ascertain information on
alcohol and drug use during pregnancy. Our definition
of alcohol abuse included indications of alcohol-induced
mental disorders (291.0–9), alcohol dependence syndrome
(303.00–93), nondependent alcohol abuse such as binge
drinking (305.00–03), alcoholic cardiomyopathy (425.5), and
alcohol that has affected the fetus or newborn via the placenta
or breast milk (760.71). Drug abuse included drug-induced
mental disorders (291.0–9), drug dependence (304.00–93),
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nondependent drug abuse (305.20–93), drug dependence
complicating pregnancy or childbirth (648.30–34), suspected
damage to the fetus from drugs (655.50–53), drugs affecting
the fetus or newborn via the placenta or breast milk (760.7273, 760.75), and poisoning by opiates and related narcotics
(965.00–09). We also considered several hospital characteristics including teaching status (teaching versus nonteaching),
location (urban versus rural), and US region (Northeast,
Midwest, South, or West).
2.1. Statistical Analysis. Descriptive statistics including frequencies and percentages were used to describe the distribution of index delivery hospitalizations across patientand hospital-level characteristics and stratified by exposure groups (HIV and TB negative, HIV monoinfection, TB monoinfection, and HIV-TB coinfection). Since
national estimates were desired, all statistical analyses were
weighted using an HCUP-provided discharge-level weight
that accounts for the NIS’s sampling design. Multivariable
survey logistic regression was then used to generate adjusted
odds ratios (OR) that quantified the magnitude of the association between infection status (i.e., HIV monoinfection,
TB monoinfection, and HIV-TB coinfection) and the main
outcomes of the study (pregnancy complications, alcohol use,
and drug abuse). Statistical analyses were performed with
SAS, version 9.4 (SAS Institute, Inc., Cary, NC); we assumed
a 5% type I error rate for all hypothesis tests (two-sided). Due
to the deidentified, publicly available nature of NIS data, the
analyses performed for this study were considered exempt by
the Baylor College of Medicine Institutional Review Board.
It is pertinent to mention that some of the results of our
analyses contained small numbers which must be suppressed
in accordance with guidelines set forth by the Healthcare
Cost and Utilization Project. The reason is to prevent possible
identification of these individuals, and, in such cases, we
described the findings in text without displaying the actual
values.

3. Results
We analyzed a total of 57,393,459 hospitalizations related to
pregnancy and delivery over the study period. The diagnosis
of active TB monoinfection was documented in 4,053 mothers yielding a rate of 7.06 per 100,000. In the entire population
of mothers, the prevalence of HIV monoinfection was 12.76
per 10,000 (𝑁 = 73,223 HIV-infected mothers). Although
the prevalence of HIV-TB coinfection was 1.9 per million
(𝑁 = 110) in the entire population of pregnant mothers, the
rate of TB among HIV-positive mothers was 150.23/100,000.
This was 21 times as high when compared to the rate of TB in
the entire population of pregnant women.
Table 1 and Figures 1(a), 1(b), and 1(c) represent a summary of sociodemographic characteristics by infection status.
HIV-TB monoinfection and HIV-TB coinfection correlated
positively with ascending age, with notable racial/ethnic
differences. The rates of HIV and HIV-TB coinfection were
highest among black mothers, while TB monoinfection was
most prevalent in Hispanics. Whereas the proportion of HIV
monoinfection, TB, and HIV-TB coinfection was 13-, 5-,
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Table 1: Distribution of sociodemographic and health facility characteristics among hospital admissions of pregnant women, by HIV/TB
status, United States, 2002–2014.
HIV/TB status

Age
13–24
25–34
35–49
Race/ethnicity
NH-White
NH-Black
Hispanic
Other
Not reported
Income
Lowest
2nd
3rd
Highest
Payer
Government
Private
Other
Hospital region
Northeast
Midwest
South
West
Hospital type
Rural
Urban, nonteaching
Urban, teaching

HIV–, TB−
𝑛 = 57.3 ma
%b

HIV+, TB−
𝑛 = 73,223
%b

TB+, HIV−
𝑛 = 4053
%b

HIV+, TB+
𝑛 = 110
%b

33.9
51.4
14.7

26.4
56.5
17.2

31.3
50.8
17.8

c
70.3
21.4

42.1
11.8
18.9
8.6
18.7

14.5
54.8
12.3
5.4
13.0

11.3
16.0
34.8
23.0
14.9

c
49.9
16.7
12.7
12.4

27.1
24.8
24.1
22.2

47.3
21.0
14.6
8.1

36.3
24.3
20.9
16.1

44.7
12.1
25.7
8.7

43.0
50.5
6.5

72.7
18.8
8.5

62.6
23.6
13.8

66.4
21.3
12.3

16.5
21.2
37.9
24.4

25.1
13.1
56.8
5.1

24.0
18.3
34.0
23.7

30.3
c
53.2
c

11.2
40.4
48.0

3.3
16.7
79.5

4.8
20.0
74.6

c
16.4
79.3

a
The estimated number of records with HIV–, TB– is 57,316,293. b Displayed percentages are column percentages. Percentages may not add to 100% due to
missing data. c Data are suppressed due to small numbers in accordance with guidelines set forth by the Healthcare Cost and Utilization Project.

and 20-fold as high among black mothers when compared
to their white counterparts, respectively, the corresponding
proportion among Hispanics was 2, 7, and 4 times as high as
that of their white counterparts, respectively. Low socioeconomic status and having public or no health insurance were
the greatest risks for HIV-TB monoinfection and HIV-TB
coinfection. Our data also portrayed geographical differences
in the rates of infection among mothers. The Northeast had
the highest rates for HIV-TB monoinfection and HIV-TB
coinfection, while the Western part of the US had relatively
low prevalence of HIV and HIV-TB coinfection. Across
health facilities, the rates for HIV-TB monoinfection and
HIV-TB coinfection were highest among urban teaching
hospitals and lowest for hospital facilities located in rural
areas.

Table 2 summarizes the rates of pregnancy complications,
alcohol use, drug abuse, and depression among pregnancyrelated hospital admissions for the entire period of the study.
Note that some of the values in the table are suppressed due
to small numbers in accordance with guidelines set forth by
the Healthcare Cost and Utilization Project. The reason is to
prevent possible identification of these individuals, and, in
such cases, we described the findings in text without displaying the actual values. Pregnancy complications as a composite
outcome were highest among HIV-TB coinfected mothers
followed by those with TB monoinfection. Since we only
observed 110 cases of HIV-TB coinfection out of the more
than 57 million hospital admissions, it was to be expected
that not all pregnancy complications would occur in the
110 HIV-TB coinfected mothers. Four (eclampsia, placenta
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HIV+ diagnoses per 100,000 discharges
50 100 150 200 250 300 350 400 450 500 550 600 650 700

0
Age

Race-ethnicity

Household income

Primary payer
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(a) Rates of HIV among hospital admissions of pregnant women by sociodemographic and health facility
characteristics in the United States, 2002–2014. Note. Error bars represent the 95% confidence interval for each rate
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Overall
13–24 years
25–34 years
35–49 years
NH-White
NH-Black
Hispanic
Other
Not reported
Lowest quartile
2nd quartile
3rd quartile
Highest quartile
Government
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(b) Rates of TB disease among hospital admissions of pregnant women by sociodemographic and health facility
characteristics in the United States, 2002–2014. Note. Error bars represent the 95% confidence interval for each rate

0
Age

Race-ethnicity

Household income

Primary payer
Region

0.2

HIV/TB coinfection diagnoses per 100,000 discharges
0.4
0.6
0.8
1
1.2

1.4

Overall
25–34 years
35–49 years
NH-Black
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Not reported
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(c) Rates of HIV-TB coinfections among hospital admissions of pregnant women by sociodemographic and health
facility characteristics in the United States, 2002–2014. Note. Error bars represent the 95% confidence interval for
each rate. Also, data for some population subgroups (age 13–24, NH-Whites, and the Midwest and West regions) are
suppressed in accordance with guidelines set forth by the Healthcare Cost and Utilization Project

Figure 1
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Table 2: Rates (per 1,000 hospitalizations) of alcohol use, drug abuse, depression, and complications of pregnancy among pregnancy-related
admissions, by HIV/TB status, United States, 2002–2014.
HIV/TB status

Alcohol use
Drug abuse
Depression
Pregnancy complications (all)
Anemia
Diabetes
Preeclampsia
Eclampsia
Placental abruption
Placenta previa
Placenta accreta
Othersc
Postpartum hemorrhage
Sepsis

HIV−, TB−
𝑛 = 57.3 ma

HIV+, TB−
𝑛 = 73,223

TB+, HIV−
𝑛 = 4053

HIV+, TB+
𝑛 = 110

1.7
16.0
20.1
166.4
102.7
11.3
23.4
1.0
10.6
5.2
3.3
3.6
25.8
1.3

16.1
114.6
53.2
272.2
214.1
24.6
23.8
1.4
11.6
5.5
2.6
4.9
21.6
5.4

4.7
25.3
25.8
292.1
216.6
16.7
24.0
2.8
8.9
9.9
1.3
3.6
45.5
8.3

b
119.08
b
331.28
206.33
b
b
b
b
b
b
b
b
b

a
The estimated number of records with HIV−, TB− is 57,316,293. b Data are suppressed in accordance with guidelines set forth by the Healthcare Cost and
Utilization Project. c Other antepartum hemorrhages.

Table 3: Adjusted odds ratios for the association between HIV infection, TB disease, and HIV-TB coinfection status and obstetrics
complications, alcohol abuse, drug abuse, and mental health among pregnancy-related admissions in the Unites States.
Status
HIV−, TB−
HIV+, TB−
TB+, HIV−
HIV+, TB+

Outcome
Pregnancy complications
1.00 (reference)
1.40 (1.32, 1.47)
1.91 (1.64, 2.23)
2.00 (0.83, 4.79)

Alcohol use
1.00 (reference)
5.12 (4.42, 5.93)
2.10 (0.79, 5.55)
11.39 (1.38, 94.06)

Drug abuse
1.00 (reference)
4.63 (4.19, 5.12)
1.39 (0.92, 2.12)
5.08 (1.43, 18.04)

Depression
1.00 (reference)
2.83 (2.60, 2.39)
1.54 (1.00, 2.39)
2.55 (0.34, 19.09)

Note. Statistically significant adjusted odds ratios (95% confidence interval does not include 1) appear in bold text. Models for all outcomes are adjusted for
age, race, income, payer, year of hospitalization, and hospital region; the model with pregnancy complications as the outcome is also adjusted for alcohol use,
drug abuse, and depression.

accreta, postpartum hemorrhage, and anemia) of the 10
pregnancy complications were detected among women with
HIV-TB coinfections. When the rates of these complications
were compared across the categories of infection status, three
of the four complications (eclampsia, placenta accreta, and
anemia) occurred with greatest frequency among HIV-TB
coinfected mothers. The only exception (postpartum hemorrhage) was highest among women with TB monoinfection.
We then compared the other remaining six complications
that had zero occurrence among HIV-TB coinfected mothers
in disease-free (no TB and no HIV), HIV-monoinfected,
and TB-monoinfected mothers. We found similar rates of
preeclampsia across the three groups. Diabetes mellitus,
placental abruption, and other sources of antepartum hemorrhages were highest among HIV-monoinfected mothers
while placenta previa and sepsis were greatest among mothers
with TB monoinfection. Alcohol abuse and drug abuse
rates were consistently greatest among mothers with HIV-TB
coinfection followed by those with HIV monoinfection while

the prevalence of depression was most pronounced among
HIV-monoinfected mothers.
Table 3 describes the association between infection status
and obstetrics complications, alcohol abuse, drug abuse, and
mental health. The risk for pregnancy complications, even
after adjustment for alcohol use, drug abuse, and depression,
was greatest among women with HIV-TB coinfection [OR
= 2.00 (0.83, 4.79)] although this 2-fold elevated risk level
did not reach statistical significance. Mothers with HIV
monoinfection exhibited the lowest likelihood for pregnancy
complications [OR = 1.40 (1.32, 1.47)]. We did observe
moderation of the effect of HIV/TB status on pregnancy
complications by substance abuse behaviors and depression.
Whereas women without any indication of alcohol use,
drug abuse, or depression had associations between HIV/TB
status and pregnancy complications that were similar to the
entire study population, measures of association were greatly
attenuated among women with substance abuse or depression
(data not shown). The likelihood for alcohol abuse was more
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than twice as high among HIV-positive patients [OR = 5.12
(4.42, 5.93)] as compared to TB-monoinfected patients [OR =
2.10 (0.79, 5.55)]. That risk gap more than doubled with HIVTB coinfection [OR = 11.39 (1.38, 94.06)]. Mothers with HIV
or HIV-TB coinfection experienced elevated risks for drug
abuse and depression almost twice as much as those with TB
monoinfection only.

4. Discussion
The prevalence of 1.9 HIV-TB coinfection cases per one
million pregnant women in our study is lower than that for
resource-limited nations, although our denominator (more
than 57 million admissions) is the largest reported. It is
noteworthy that the rate of TB among HIV-positive mothers
was 150.23/100,000 in the population we analyzed, which was
21 times as high when compared to the rate of TB in the entire
population of pregnant women analyzed. This demonstrates
the extremely high vulnerability of HIV-infected persons
to TB disease. People infected with HIV are at high risk
for developing active TB due to either the reactivation of
a latent infection or the progression of newly acquired
tubercle bacilli infections. Among HIV-positive individuals,
the immune responses to tubercle bacilli may not be effective
due to underlying HIV-induced immunological aberrations
which weaken effector immune responses [13, 14]. Results
from immune phenotyping studies indicate that peripheral
CD4+T cells from a subset of HIV-positive patients on ART
regimens still continue to manifest characteristic features
of pronounced cellular exhaustion [15], turnover [16], and
senescence [17]. These aberrant immunological patterns will
explain the raised likelihood of tuberculosis disease and
reactivation of latent tuberculosis in HIV-positive pregnant
mothers as reported in this study.
We also found HIV-TB coinfection to be associated with
the greatest risk for pregnancy complications as compared
to HIV and TB monoinfection status. However, the almost
2-fold elevated risk among HIV-TB coinfected mothers had
a wide confidence interval that encompassed the null. This
might be due to the small number of cases. Nonetheless,
our results are in congruence with previous studies in lowresource high-HIV prevalence settings which demonstrated
significant maternal morbidity and mortality in pregnant
women with HIV-TB coinfection [18–20]. In a recent analysis
by Canadian authors utilizing the same dataset covering
the period 2003 to 2011, the investigators reported elevated
risks of chorioamnionitis, preterm labor, postpartum anemia, blood transfusion, and pneumonia as well as maternal
mortality among pregnant women with tuberculosis disease
[10]. Our study showed that HIV-coinfected women were
particularly at high risk for eclampsia, placenta accreta, and
anemia. The heightened risks of maternal complications
among mothers with HIV-TB coinfection represent a pathway for the increased risk of maternal mortality consistently
reported among HIV-positive mothers with TB coinfection.
We also observed elevated risk for alcohol use which was
more than twice as high among HIV-positive patients [OR
= 5.12 (4.42, 5.93)] as compared to TB-monoinfected patients
[OR = 2.10 (0.79, 5.55)]. That risk gap more than doubled with
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HIV-TB coinfection [OR = 11.39 (1.38, 94.06)]. Mothers with
HIV or HIV-TB coinfection experienced elevated risks for
drug abuse and depression, almost twice as much as those
with TB monoinfection only. A potential mechanism that
explains the strong positive association between HIV positivity and excessive alcohol use, drug abuse, and depression
is perceived stress [21]. HIV-positive persons who experience
the greatest stress in their daily lives are those who disengage
behaviorally/emotionally in coping with their illness and
those who approach their interpersonal relationships in a
less secure or more anxious style [22]. By contrast, studies
indicate that, for people with HIV or AIDS, those individuals
who are more satisfied with their relationships, securely
engaged with others, and more directly engaged with their
illness are more likely to experience positive adjustment [23–
25]. It is noteworthy to mention that reverse causality does
exist in the relationships between HIV on one hand and
alcohol use/drug abuse on the other, since drug abusers and
alcohol users tend to engage in behaviors that put them at
elevated risk for HIV infection [26, 27]. The nature of social
support could also influence the likelihood of risk behaviors
among HIV-positive individuals. Previous investigators have
noted the importance of the lack of positive social support or
the existence of “negative” support as an important factor that
encourages sexual and drug-related HIV risk behavior such
that illegal drug use by members of a social network often
provides peer support for continued risk behavior [28]. Our
results tend to suggest that the concomitant existence of TB
disease among HIV-positive individuals increased the risk for
alcohol use and drug abuse although the magnitude of the
excess risk was more pronounced for alcohol use.
The results of our analysis underscore the importance
of augmenting and enhancing social and structural support
systems for HIV-TB coinfected pregnant women because of
the increased risk for pregnancy complications in addition to
the associated raised likelihood of alcohol use and drug abuse.
Given the significant findings in this study, tailored interventions are needed to maximize the effectiveness of management modalities of HIV-TB coinfected pregnant mothers
in order to prevent or mitigate the health consequences of
concomitant alcohol use, drug abuse, and depression. It is
recommended that HIV-TB coinfected mothers be supported
with sufficient provider-patient communication and contact
time before discharge in order to reinforce understanding of
their condition and link them with community assets to cater
for their future needs and care related to sustained pregnancy
complications.
Even though the dataset used for this study is nationally
representative and rich with an array of clinical and epidemiologic measures, certain limitations merit mentioning.
It is logical to assume that the quality of care received for
the management of HIV and TB among the mothers in this
study would vary considerably across the diverse population
settings in the United States. We lack a marker/measure of
quality of care or adherence with HIV care protocols in
the dataset to assess variation in quality of management
of HIV and TB conditions which could have influenced
the occurrence of the maternal pregnancy complications
examined in this study. It is notable that 60% of the pregnancy
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complications were not detected among women with HIVTB coinfection due to the rarity of HIV-TB coinfection (1.9
cases per million). Another shortcoming in this study is
the lack of biological markers (e.g., CD4 cell count and
HIV load) to predict mothers that were likely to develop
pregnancy complications, or to determine the association
of these biologic markers with alcohol use, drug abuse, or
depression. Despite these limitations, our analysis is based
on the most powerful data so far in terms of sample size
(57 million) for the source population of HIV-TB coinfected
pregnant women and the range of outcomes examined in our
study.
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